First Wave BioPharma, Inc. (NASDAQ:FWBI – Get Rating) saw a large growth in short interest during the month of June. As of June 15th, there was short interest totalling 1,050,000 shares, a growth of 1,701.0% from the May 31st total of 58,300 shares. Approximately 24.9% of the shares of the stock are short sold. Based […]